Literature DB >> 21278224

Total recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect?

C Bourgier, C Massard, C Moldovan, J-C Soria, E Deutsch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278224     DOI: 10.1093/annonc/mdq741

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

Review 1.  Radiotherapy and "new" drugs-new side effects?

Authors:  Maximilian Niyazi; Cornelius Maihoefer; Mechthild Krause; Claus Rödel; Wilfried Budach; Claus Belka
Journal:  Radiat Oncol       Date:  2011-12-21       Impact factor: 3.481

2.  Radiation Recall Pneumonitis During Systemic Treatment With Everolimus.

Authors:  Douglas Clark; Dron Gauchan; Ryan Ramaekers; Max Norvell; Mehmet Sitki Copur
Journal:  Oncol Res       Date:  2014       Impact factor: 5.574

3.  Fatal bleeding in a nasopharyngeal carcinoma patient after concurrent chemoradiation plus cetuximab: a case report.

Authors:  Lingyan Zheng; Senxiang Yan; Danfang Yan; Jingsong Yang; Yixiang Wang
Journal:  Onco Targets Ther       Date:  2013-06-13       Impact factor: 4.147

4.  Molecular guided therapy for advanced pancreatic cancer patients with PI3K activated mutation: vision or illusion?

Authors:  Anas Gazzah; Daniel Barrios Gonzales; Antonin Levy; Rastislav Bahleda; Michel Ducreux; Ludovic Lacroix; Jean Charles Soria
Journal:  Onco Targets Ther       Date:  2013-02-20       Impact factor: 4.147

5.  Radiation-induced esophagitis exacerbated by everolimus.

Authors:  Yuji Miura; Koichi Suyama; Akihiko Shimomura; Jimpei Miyakawa; Hiroki Kobayashi; Akiyoshi Uki; Toshikazu Okaneya; Toshimi Takano
Journal:  Case Rep Oncol       Date:  2013-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.